Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrator complex subunit 3 (INTS3) is a multifunctional protein that plays critical roles in both the maintenance of genome stability and in transcriptional regulation. As part of the SOSS complex, INTS3 participates in the cellular DNA damage response by promoting the repair of double-strand DNA breaks through homologous recombination and facilitating activation of ATM-dependent checkpoint signaling[1][2]. It scaffolds other SOSS components, including single-stranded DNA-binding proteins, and stabilizes the complex at DNA damage sites[1][2]. INTS3 is also a component of the Integrator complex, which regulates transcription termination by RNA polymerase II: it helps in processing small nuclear RNAs, enhancer RNAs, and additional noncoding and coding transcripts by facilitating termination in the promoter-proximal region[1][3]. Mutations or deficiency in INTS3 have been linked to genomic instability and cancer susceptibility[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrator complex subunit 3 (INTS3).